Invest now
Aarti Pharmalabs Balance Sheet Annual
BSE: 543748 | NSE: AARTIPHARM | ISIN: INE0LRU01027 | Sector: Biotechnology & Drugs790.35 +1.05 (0.13%)Updated : 16 Sep 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 3,481.71 | 2,902.43 | 2,582.11 | 2,230.93 |
| Accumulated Depreciation Total | -645.67 | -614.71 | -536.85 | -467.57 |
| Cash Equivalents | 0.00 | - | - | 12.81 |
| Other Liabilities Total | 32.21 | 8.12 | 6.06 | 1.32 |
| Accrued Expenses | 24.22 | 19.95 | 15.26 | 13.04 |
| Long Term Debt | 200.81 | 111.26 | - | - |
| Common Stock Total | 45.33 | 45.32 | 45.31 | 45.31 |
| Other Equity Total | -9.37 | -5.07 | 8.06 | 8.52 |
| Other Current Assets Total | 0.72 | 0.35 | 0.00 | - |
| Prepaid Expenses | 8.72 | 6.34 | 6.15 | 2.32 |
| Total Assets | 3,481.71 | 2,902.43 | 2,582.11 | 2,230.93 |
| Current Portof LT Debt/ Capital Leases | 59.43 | 5.09 | 4.49 | 0.82 |
| Additional Paid- In Capital | 441.92 | 440.76 | 440.33 | 440.33 |
| Cash | 8.53 | 6.73 | 24.07 | 12.19 |
| Total Equity | 2,124.60 | 1,989.91 | 1,757.04 | 1,558.49 |
| Long Term Investments | 193.85 | 29.24 | 36.78 | 35.52 |
| Retained Earnings( Accumulated Deficit) | 1,643.82 | 1,504.57 | 1,263.34 | 1,064.33 |
| Total Common Shares Outstanding | 9.07 | 9.06 | 9.06 | 9.06 |
| Property/ Plant/ Equipment Total- Gross | 2,352.33 | 2,025.42 | 1,630.04 | 1,453.65 |
| Tangible Book Valueper Share Common Eq | 220.69 | 208.49 | 185.38 | 167.38 |
| Goodwill Net | 0.00 | 1.78 | 1.78 | 1.78 |
| Total Liabilities | 1,357.10 | 912.52 | 825.07 | 672.44 |
| Total Debt | 769.36 | 420.82 | 285.25 | 215.31 |
| Short Term Investments | 0.37 | 49.12 | 76.68 | 73.99 |
| Cashand Short Term Investments | 8.90 | 55.86 | 100.74 | 98.99 |
| Total Receivables Net | 695.22 | 653.04 | 589.31 | 452.40 |
| Notes Payable/ Short Term Debt | 456.94 | 292.80 | 264.06 | 213.78 |
| Deferred Income Tax | 134.33 | 128.40 | 107.92 | 78.84 |
| Accounts Receivable- Trade Net | 583.32 | 575.45 | 519.34 | 440.05 |
| Property/ Plant/ Equipment Total- Net | 1,706.66 | 1,410.70 | 1,093.19 | 986.08 |
| Total Current Liabilities | 937.57 | 653.07 | 694.39 | 591.57 |
| Total Inventory | 683.73 | 602.60 | 649.44 | 602.04 |
| Accounts Payable | 334.54 | 277.83 | 378.32 | 346.76 |
| Other Currentliabilities Total | 62.44 | 57.41 | 32.26 | 17.17 |
| Total Long Term Debt | 252.99 | 122.93 | 16.70 | 0.72 |
| Intangibles Net | 123.89 | 98.44 | 75.27 | 39.85 |
| Other Long Term Assets Total | 35.43 | 14.03 | 11.33 | 9.44 |
| Note Receivable- Long Term | 24.59 | 30.05 | 18.11 | 2.49 |
| Unrealized Gain( Loss) | 2.91 | 4.34 | - | - |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,397.29 | 1,318.19 | 1,345.64 | 1,155.76 |
| Capital Lease Obligations | 52.18 | 11.67 | 16.70 | 0.72 |
*All figures in crores except per share values
Aarti Pharmalabs Quick Links
Aarti Pharmalabs Dividend Aarti Pharmalabs Bonus Aarti Pharmalabs News Aarti Pharmalabs AGM Aarti Pharmalabs Rights Aarti Pharmalabs Splits Aarti Pharmalabs Board Meetings Aarti Pharmalabs Key Metrics Aarti Pharmalabs Shareholdings Aarti Pharmalabs Profit Loss Aarti Pharmalabs Cashflow Aarti Pharmalabs Q1 Results Aarti Pharmalabs Q2 Results Aarti Pharmalabs Q3 Results Aarti Pharmalabs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
272.00+6.05(2.27%)
1,260.00+20.50(1.65%)
11,053.00+157.00(1.44%)
1,196.80-29.75 (-2.43%)
185.95-2.60 (-1.38%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.